Cardiovascular risk factors in chronic renal failure and hemodialysis populations

K. W. Ma, E. L. Greene, Leopoldo Raij

Research output: Contribution to journalArticle

239 Citations (Scopus)

Abstract

Cardiovascular disease is the leading cause of death in patients with end- stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study.

Original languageEnglish
Pages (from-to)505-513
Number of pages9
JournalAmerican Journal of Kidney Diseases
Volume19
Issue number6
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Chronic Kidney Failure
Renal Dialysis
Cardiovascular Diseases
Population
Glucose Intolerance
Left Ventricular Hypertrophy
Renal Insufficiency
Cause of Death
Hypertension
Morbidity
Lipids
Mortality
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Cardiovascular risk factors in chronic renal failure and hemodialysis populations. / Ma, K. W.; Greene, E. L.; Raij, Leopoldo.

In: American Journal of Kidney Diseases, Vol. 19, No. 6, 01.01.1992, p. 505-513.

Research output: Contribution to journalArticle

Ma, K. W. ; Greene, E. L. ; Raij, Leopoldo. / Cardiovascular risk factors in chronic renal failure and hemodialysis populations. In: American Journal of Kidney Diseases. 1992 ; Vol. 19, No. 6. pp. 505-513.
@article{72eab084a7574a6e9537d0c8da22734b,
title = "Cardiovascular risk factors in chronic renal failure and hemodialysis populations",
abstract = "Cardiovascular disease is the leading cause of death in patients with end- stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study.",
author = "Ma, {K. W.} and Greene, {E. L.} and Leopoldo Raij",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "19",
pages = "505--513",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Cardiovascular risk factors in chronic renal failure and hemodialysis populations

AU - Ma, K. W.

AU - Greene, E. L.

AU - Raij, Leopoldo

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Cardiovascular disease is the leading cause of death in patients with end- stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study.

AB - Cardiovascular disease is the leading cause of death in patients with end- stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study.

UR - http://www.scopus.com/inward/record.url?scp=0026751686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026751686&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 505

EP - 513

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -